Market Overview:
The global breast imaging market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 4.5 Billion |
Market Forecast in 2032
|
US$ 8.8 Billion |
Market Growth Rate 2024-2032 |
7.5% |
Breast imaging refers to the radiological technique of diagnosing breast cancer in both males and females. It involves a range of equipment to screen, detect and determine the location of the tumor and other breast-related infections, lesions and cysts. It also entails various procedures such as mammography, breast biopsy, ultrasound, tactile imaging and Magnetic Resonance Imaging (MRI). The aim of conducting these procedures is to detect the disease at its earliest and most treatable stage. Procedures such as mammography produce digital images in which the brightness, darkness and contrast can be altered as per the requirement, thus making the differentiation between malignant and benign cells simpler. These procedures are considered safe, are non-invasive and cause minimum discomfort to the patient.
Global Breast Imaging Market Trends and Drivers:
The increasing prevalence of breast cancer, along with the rising awareness of the early detection of the disease, is among the key factors driving the growth of the market. Furthermore, the growing geriatric population, which is more susceptible to such ailments, are also contributing to the increased adoption rate of breast imaging procedures. Various technological advancements in the imaging equipment have enabled improved diagnosis of dense breast tissues. Patients are increasingly opting for digital mammography systems that offer high detection rates in comparison to traditionally used analog devices. Additionally, various organizations and healthcare centers are conducting cancer awareness campaigns to educate individuals about breast health and cancer diagnostic measures. Moreover, technological innovations such as the introduction of breast tomosynthesis or 3D mammography, rising healthcare expenditure, growing disposable income, and government initiatives to improve cancer screening and diagnosis are also driving the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and end-user.
Breakup by Technology:
- Ionizing Breast Imaging
- Mammography
- Positron Emission Tomography-Computed Tomography
- Molecular Breast Imaging
- Positron Emission Mammography
- Cone-Beam Computed Tomography
- Non-Ionizing Breast Imaging
- Breast Ultrasound
- Breast MRI
- Automated Whole-Breast Ultrasound
- Breast Thermography
- Electric Impedance Tomography
- Optical Imaging
Breakup by End-User:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allengers Medical Systems Limited, Aurora Health Care Inc. (Schoen Clinic), Canon Inc., Carestream Health Inc. (Onex Corporation), Delphinus Medical Technologies, Dilon Technologies Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., Micrima Limited, Planmed Oy, Siemens Healthineers AG (Cerner Corporation), Toshiba Corporation, etc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Technology, End-User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Allengers Medical Systems Limited, Aurora Health Care Inc. (Schoen Clinic), Canon Inc., Carestream Health Inc. (Onex Corporation), Delphinus Medical Technologies, Dilon Technologies Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., Micrima Limited, Planmed Oy, Siemens Healthineers AG (Cerner Corporation), Toshiba Corporation |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global breast imaging market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global breast imaging market?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global breast imaging market and who are the key players?
- What is the degree of competition in the industry?